Free Trial

Sabra Healthcare REIT (NASDAQ:SBRA) Coverage Initiated at Cantor Fitzgerald

Sabra Healthcare REIT logo with Finance background

Key Points

  • Sabra Healthcare REIT has been upgraded to a "hold" rating by analysts at Cantor Fitzgerald.
  • Several brokerages have raised their target prices for Sabra, with Scotiabank and Wells Fargo targeting $20.00 and $21.00, respectively.
  • The company reported better-than-expected earnings, posting $0.38 EPS for the last quarter, exceeding the consensus estimate of $0.36.
  • Five stocks to consider instead of Sabra Healthcare REIT.

Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) in a research note issued to investors on Wednesday, MarketBeat reports. The brokerage set a "neutral" rating and a $20.00 price target on the real estate investment trust's stock. Cantor Fitzgerald's price objective would indicate a potential upside of 8.93% from the company's current price.

Other equities analysts have also recently issued research reports about the company. Truist Financial upped their price target on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a report on Tuesday, September 2nd. JMP Securities increased their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a "market outperform" rating in a research note on Wednesday, August 6th. Wells Fargo & Company increased their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday, August 27th. Scotiabank increased their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research note on Monday, June 23rd. Finally, BMO Capital Markets increased their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research note on Monday, August 25th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Sabra Healthcare REIT currently has an average rating of "Moderate Buy" and an average target price of $20.71.

Check Out Our Latest Analysis on Sabra Healthcare REIT

Sabra Healthcare REIT Stock Down 1.5%

NASDAQ SBRA opened at $18.36 on Wednesday. The stock has a market cap of $4.40 billion, a PE ratio of 24.16, a P/E/G ratio of 1.49 and a beta of 0.85. Sabra Healthcare REIT has a fifty-two week low of $15.60 and a fifty-two week high of $20.03. The business has a 50 day moving average price of $18.78 and a two-hundred day moving average price of $18.14. The company has a quick ratio of 4.80, a current ratio of 4.80 and a debt-to-equity ratio of 0.91.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. The firm had revenue of $189.15 million during the quarter, compared to analysts' expectations of $185.64 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.Sabra Healthcare REIT's quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, sell-side analysts predict that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Hedge Funds Weigh In On Sabra Healthcare REIT

Large investors have recently added to or reduced their stakes in the company. SVB Wealth LLC bought a new position in Sabra Healthcare REIT during the first quarter worth $34,000. UMB Bank n.a. increased its position in Sabra Healthcare REIT by 379.6% in the first quarter. UMB Bank n.a. now owns 2,048 shares of the real estate investment trust's stock worth $36,000 after buying an additional 1,621 shares during the period. Wealth Preservation Advisors LLC acquired a new stake in Sabra Healthcare REIT in the first quarter worth $38,000. EverSource Wealth Advisors LLC increased its position in Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust's stock worth $47,000 after buying an additional 1,536 shares during the period. Finally, Northwestern Mutual Wealth Management Co. increased its position in Sabra Healthcare REIT by 61.2% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,806 shares of the real estate investment trust's stock worth $49,000 after buying an additional 1,065 shares during the period. 99.40% of the stock is currently owned by institutional investors.

About Sabra Healthcare REIT

(Get Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Featured Articles

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Should You Invest $1,000 in Sabra Healthcare REIT Right Now?

Before you consider Sabra Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.

While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.